Zdrowie i gospodarka · 16/09/2020

FDA Announces Final Guidance for Developing Drugs to Treat Eosinophilic Esophagitis

The FDA has released a final guidance document outlining its approach for developing treatments for eosinophilic esophagitis, a condition that affects patients and for which the agency is seeking new drug and biologic therapies